Trulance vs Linzess: Key Differences and How Doctors Tell Them Apart

Trulance and Linzess are prescription medicines that can treat chronic idiopathic constipation and constipation-predominant irritable bowel syndrome (IBS-C) in adults. Both work similarly, but their active ingredients, instructions for taking them, approved uses and suitability for an individual can differ.

Trulance vs Linzess: a side-by-side comparison

In the comparison of Trulance vs Linzess, the most important point is that both are prescription treatments for constipation disorders, not general-purpose laxatives. They act on receptors in the intestinal lining to increase fluid in the bowel, soften stool and support more regular bowel movements. A prescriber can help determine whether either medicine is appropriate after considering the cause of constipation.

Feature	Trulance	Linzess
Active ingredient	Plecanatide	Linaclotide
Medicine class	Guanylate cyclase-C agonist	Guanylate cyclase-C agonist
Common adult uses	Chronic idiopathic constipation and IBS-C	Chronic idiopathic constipation and IBS-C
How it is taken	Usually once daily, with or without food	Usually once daily on an empty stomach, at least 30 minutes before the first meal of the day
Most common side effect	Diarrhea	Diarrhea
Important restriction	Not for known or suspected mechanical gastrointestinal obstruction	Not for known or suspected mechanical gastrointestinal obstruction

The medications are not interchangeable without professional guidance. Although their effects overlap, a person may respond differently to each one, and product labeling, administration instructions and age-related recommendations are not the same. The prescription label and the clinician’s advice should always take priority over general information.

What conditions do these medicines treat?

Trulance and Linzess are commonly prescribed for chronic idiopathic constipation, often shortened to CIC. This term describes ongoing constipation without an identified structural, metabolic or medication-related cause after an appropriate medical assessment. Symptoms may include infrequent stools, hard or lumpy stools, straining, a feeling of incomplete emptying or the need to use manual maneuvers to pass stool.

They may also be used for irritable bowel syndrome with constipation, known as IBS-C. In IBS-C, constipation occurs alongside recurrent abdominal pain related to bowel movements and changes in stool frequency or form. Because these medicines can increase intestinal fluid and movement, they may improve constipation and some abdominal symptoms for suitable patients.

Constipation can also result from medicines, low fiber intake, dehydration, reduced activity, thyroid disease, pelvic floor problems or bowel obstruction. In these situations, treating the underlying factor may be more important than starting a prescription secretagogue. A clinician should assess new, persistent or changing bowel symptoms rather than assuming that all constipation is CIC or IBS-C.

How do Trulance and Linzess work?

Plecanatide and linaclotide belong to the same medicine class, called guanylate cyclase-C agonists. They work mainly in the lining of the small intestine, where they activate guanylate cyclase-C receptors. This increases the movement of chloride and bicarbonate into the intestinal tract, allowing water to follow.

More fluid in the intestine can make stool easier to pass and may help bowel movements occur more regularly. These medicines also support intestinal transit, meaning the movement of contents through the digestive tract. Their action is mostly local within the gut, with very limited absorption into the bloodstream.

Despite their similar mechanism, the two active ingredients are different molecules. This does not mean one is universally stronger or better than the other. Instead, response can vary between individuals, and treatment decisions are usually based on the diagnosis, safety considerations, ability to follow the directions and the person’s experience with treatment.

How a clinician tells Trulance and Linzess apart

A clinician begins by confirming what type of constipation is present. They may ask how long symptoms have occurred, how often bowel movements happen, what the stool looks like, whether abdominal pain improves after a bowel movement and whether there are warning signs such as bleeding or unintentional weight loss. This helps distinguish CIC and IBS-C from other digestive conditions.

Practical instructions are one meaningful difference. Trulance is generally taken once daily and may be taken with or without food. Linzess is generally taken once daily on an empty stomach, at least 30 minutes before the first meal. For someone whose morning routine makes fasting administration difficult, this distinction may influence the choice.

Age and indication also matter. Approved uses can differ by country, formulation and patient age, and pediatric guidance is particularly important. Both medicines carry important warnings about dehydration risk in very young children and should be kept out of children’s reach. A clinician will use the current local prescribing information and will not prescribe either medicine for a person with known or suspected mechanical gastrointestinal obstruction.

The decision also includes prior treatments. Many people first try dietary adjustments, activity, hydration when appropriate, fiber or osmotic laxatives. If these measures do not provide adequate relief, or if IBS-C symptoms are persistent, a prescription medicine may be considered as part of an individualized plan.

What to do for each situation

For chronic idiopathic constipation, the aim is usually to achieve more comfortable, regular bowel movements while minimizing side effects. A clinician may recommend lifestyle measures and review medications that can worsen constipation before, alongside or instead of prescription therapy. If Trulance or Linzess is prescribed, it should be taken exactly as directed rather than only on days when constipation feels especially severe.

For IBS-C, care also focuses on abdominal pain, bloating and the effect symptoms have on daily life. Food patterns, stress, sleep, physical activity and the gut-brain connection can all influence symptoms. Some people benefit from a dietitian-guided dietary approach or other IBS-focused treatments in addition to medicines that improve constipation.

If a person has a history of swallowing difficulties, they should discuss this with the prescribing clinician or pharmacist. Product-specific instructions may explain whether a tablet or capsule can be handled in a particular way, such as mixing with certain soft foods or water. Tablets and capsules should not be altered unless the official instructions specifically allow it.

People should not take both medicines together unless a specialist has explicitly advised this. Combining treatments with similar bowel-stimulating effects could increase the chance of diarrhea, dehydration or discomfort without necessarily improving results.

Side effects, precautions and self-care

Diarrhea is the most frequently reported side effect of both Trulance and Linzess. It can begin early in treatment and is often mild, but it may be significant for some people. Loose stools, urgency, abdominal discomfort, gas or bloating may also occur. Side effects should be discussed with the prescribing team, especially if they interfere with work, travel, sleep or adequate fluid intake.

Severe diarrhea can lead to dehydration. A person who develops severe diarrhea should stop the medicine and contact a healthcare professional promptly for advice. Signs that may suggest dehydration include marked thirst, dizziness, fainting, unusual weakness, confusion, very dry mouth or passing much less urine than usual.

Helpful self-care for constipation may include gradually increasing fiber when it is tolerated, drinking sufficient fluids for individual health needs, staying physically active and setting aside unhurried time for bowel movements. Fiber does not help everyone with IBS-C and can worsen gas or bloating in some people, so changes should be gradual and individualized.

Before starting either medicine, patients should tell their clinician about all prescription medicines, non-prescription products and supplements they use. They should also mention pregnancy, breastfeeding, past bowel surgery, significant digestive disease and any history of severe diarrhea. Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals can assess persistent digestive symptoms and discuss suitable treatment options for international patients.

When to seek medical care

Medical assessment is advisable for constipation that is new, persistent, worsening or not improving with reasonable self-care. It is particularly important when symptoms begin after age 50, follow a major change in health or medication, or substantially affect eating, sleep or daily activities. A clinician can identify whether testing is needed and help avoid unnecessary or unsuitable treatment.

Urgent medical care is needed for severe or worsening abdominal pain, a swollen abdomen, repeated vomiting, inability to pass stool or gas, fainting, black stools or visible rectal bleeding. These symptoms can have causes other than routine constipation and should not be treated by simply increasing laxatives or taking a constipation prescription medicine.

People taking Trulance or Linzess should contact their healthcare team promptly if severe diarrhea develops, particularly if it occurs with dizziness, weakness or reduced urination. They should also seek advice if symptoms do not improve after an adequate clinician-directed trial, because the diagnosis or treatment plan may need to be reconsidered.

Frequently asked questions

Is Trulance better than Linzess?

Neither medicine is better for every person. Both can be effective for chronic idiopathic constipation and IBS-C, but individual response, side effects, dosing instructions and medical history can guide the choice. A clinician can help select the most suitable option.

What is the main difference between Trulance and Linzess?

The main difference is the active ingredient: Trulance contains plecanatide and Linzess contains linaclotide. They are in the same medicine class and work in similar ways, but their administration instructions and approved uses may differ. Linzess is generally taken on an empty stomach, while Trulance can generally be taken with or without food.

Can Trulance or Linzess cause diarrhea?

Yes. Diarrhea is the most common side effect of both medicines because they increase fluid in the intestines. Severe diarrhea is less common but needs prompt medical advice, especially if there are signs of dehydration.

Can a person switch from Linzess to Trulance?

A switch may be considered when a person does not get enough benefit, has troublesome side effects or finds the dosing routine difficult. The change should be guided by the prescribing clinician, who can review the diagnosis and provide instructions for starting the new medicine. A person should not switch or combine them independently.

How quickly do Trulance and Linzess work?

Some people notice a change in bowel movements relatively early, while others may need more time to judge the overall benefit. Response can vary based on the condition being treated, diet, other medicines and individual bowel patterns. The prescriber can advise how long to continue treatment before assessing whether it is helping.

Who should not take Trulance or Linzess?

Neither medicine should be used by someone with known or suspected mechanical gastrointestinal obstruction. They also have important pediatric safety restrictions because of the risk of serious dehydration in very young children. Anyone who is pregnant, breastfeeding, has significant digestive symptoms or is considering treatment for a child should speak with a qualified clinician.

References

• U.S. Food and Drug Administration
• American College of Gastroenterology
• National Institute of Diabetes and Digestive and Kidney Diseases
• Mayo Clinic

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.